Mirae Asset Global Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.7K | Buy |
5,474
+715
| +15% | +$12K | ﹤0.01% | 1154 |
|
|
2025
Q1 | $71.8K | Buy |
4,759
+207
| +5% | +$3.12K | ﹤0.01% | 1172 |
|
|
2024
Q4 | $102K | Hold |
4,552
| – | – | ﹤0.01% | 1141 |
|
|
2024
Q3 | $79.5K | Buy |
4,552
+146
| +3% | +$2.55K | ﹤0.01% | 1224 |
|
|
2024
Q2 | $71.6K | Buy |
+4,406
| New | +$71.6K | ﹤0.01% | 1185 |
|
|
2017
Q1 | – | Sell |
-85,933
| Closed | -$3.12M | – | 668 |
|
|
2016
Q4 | $3.12M | Buy |
85,933
+2,168
| +3% | +$78.6K | 0.07% | 194 |
|
|
2016
Q3 | $3.86M | Sell |
83,765
-19,658
| -19% | -$905K | 0.08% | 165 |
|
|
2016
Q2 | $5.19M | Buy |
103,423
+42,617
| +70% | +$2.14M | 0.13% | 121 |
|
|
2016
Q1 | $3.25M | Sell |
60,806
-907
| -1% | -$48.5K | 0.09% | 169 |
|
|
2015
Q4 | $4.05M | Buy |
61,713
+6,809
| +12% | +$447K | 0.13% | 144 |
|
|
2015
Q3 | $3.1M | Buy |
54,904
+9,804
| +22% | +$554K | 0.13% | 155 |
|
|
2015
Q2 | $2.67M | Sell |
45,100
-27,420
| -38% | -$1.62M | 0.09% | 177 |
|
|
2015
Q1 | $4.52M | Buy |
72,520
+21,218
| +41% | +$1.32M | 0.15% | 112 |
|
|
2014
Q4 | $2.95M | Buy |
51,302
+23,423
| +84% | +$1.35M | 0.11% | 128 |
|
|
2014
Q3 | $1.5M | Buy |
27,879
+5,991
| +27% | +$322K | 0.05% | 207 |
|
|
2014
Q2 | $1.15M | Buy |
21,888
+2,438
| +13% | +$128K | 0.03% | 236 |
|
|
2014
Q1 | $1.03M | Sell |
19,450
-7,200
| -27% | -$381K | 0.03% | 247 |
|
|
2013
Q4 | $1.07M | Sell |
26,650
-1,840
| -6% | -$73.7K | 0.04% | 270 |
|
|
2013
Q3 | $1.08M | Sell |
28,490
-1,360
| -5% | -$51.4K | 0.05% | 241 |
|
|
2013
Q2 | $1.17M | Buy |
+29,850
| New | +$1.17M | 0.06% | 211 |
|